Brought to you by the National Minority Quality Forum with support from Pfizer, Inc.
©2010, National Minority Quality Forum. All Rights Reserved
| |
|
|
||||
| |
||||||
|
|
||||||
|
|
||||||
| |
|
|
||||
|
|
Identifying where lung cancer is most prevalent can help to encourage early screening and detection efforts, particularly among at-risk populations who are disproportionately affected. |
|
||||
|
|
|
|||||
Brought to you by the National Minority Quality Forum with support from Pfizer, Inc. ©2010, National Minority Quality Forum. All Rights Reserved |
||||||
|
|
|
|
|
|
|
|